- Report
- March 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2025
- 250 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- January 2025
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- May 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- May 2024
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- May 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- August 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- April 2024
- 407 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- December 2024
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- February 2025
- 340 Pages
Global
From €4638EUR$4,860USD£3,886GBP
- Report
- March 2025
- 181 Pages
Asia Pacific
From €2720EUR$2,850USD£2,279GBP
- Report
- January 2025
- 135 Pages
United States
From €2376EUR$2,490USD£1,991GBP
- Report
- August 2024
- 310 Pages
Europe
From €2376EUR$2,490USD£1,991GBP
- Report
- May 2024
- 132 Pages
North America
From €3818EUR$4,000USD£3,199GBP
- Report
- July 2024
- 148 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- April 2024
- 170 Pages
Middle East, Africa
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 172 Pages
Asia Pacific
From €1432EUR$1,500USD£1,199GBP

The Nucleic Acid Amplification (NAA) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. NAA is a technique used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. It is used in a wide range of applications, including clinical diagnostics, food safety testing, and environmental monitoring. NAA is a highly sensitive and specific method for detecting and quantifying nucleic acids, and is increasingly being used in IVD applications.
NAA technology is used in a variety of IVD tests, including infectious disease testing, genetic testing, and cancer diagnostics. It is also used in the development of new diagnostic tests, such as those for emerging infectious diseases. NAA technology is also being used in the development of personalized medicine, allowing for the detection of genetic mutations that may be associated with certain diseases.
The NAA market is expected to continue to grow in the coming years, driven by the increasing demand for IVD tests and the development of new technologies. Major players in the NAA market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Qiagen, and Thermo Fisher Scientific. Show Less Read more